Palmitoylethanolamide (PEA) Explained Simply

1. What It Is About

Palmitoylethanolamide, abbreviated as PEA, is a substance that the body produces itself. The studies describe it as a messenger that dampens inflammation, thus a kind of signal by which cells inhibit one another. PEA is supplied as a food supplement and not as a classic medicinal product. It has been known as a component of food since 1957; it was first obtained from soya lecithin, egg yolk and peanut meal. Since a study by the Nobel laureate Levi-Montalcini in 1993, pain has been at the centre of research, especially pain originating from damaged nerves. Two things must be distinguished: the messenger substance in the body and the preparation that is taken. The preparations come in two forms. In one, the powder is finely ground, in the other much finer; this is called micronised and ultramicronised. Finer grinding is intended to make the substance better absorbable. Whether this is true has not been directly compared.

2. What Studies Show

Chronic pain is the best studied. A 2023 review pooled eleven double-blind studies with 774 people 4. Double-blind means neither the treated nor the treating know who receives which preparation. In the pooled analysis, pain scores fell under PEA compared with the control groups. These controls included placebo and other analgesics together; the size of the difference from placebo alone cannot be read from this. In knee osteoarthritis, a double-blind study compared 111 adults over eight weeks 3. One part received placebo, the others received PEA. In both PEA groups, symptoms and pain decreased more markedly than under placebo; the participants assessed their situation themselves with a questionnaire. In 70 people with diabetes and nerve pain, PEA and placebo were tested for eight weeks 8. Under PEA, nerve pain and impairment in daily life decreased, and sleep quality improved. Mood scores for low mood also improved; anxiety and stress scores did not. Certain inflammatory markers in the blood fell; such laboratory values are measurements, not symptoms. In 42 people with carpal tunnel syndrome who were awaiting surgery and suffered from pain and sleep disturbances, PEA was given before and after surgery 5. Sleep quality and pain improved. There was no placebo group here, and the authors themselves describe their results as preliminary. In burning-mouth syndrome, a persistent burning sensation in the mouth, a preliminary double-blind study tested PEA over 60 days 7. The burning sensation decreased more strongly in the PEA group than under placebo; no adverse effects were observed. A 2016 review examined sixteen clinical studies on tolerability 1. For treatments up to 49 days, the data spoke against serious adverse effects.

3. What Remains Unclear

A large part of the studies tests PEA not alone but together with other substances, for example with luteolin, with trans-polydatin or with cannabidiol. From such studies it cannot be said what share PEA had in the result. In one study on olfactory disorders after COVID-19, exactly such a combination was tested 2, likewise in pelvic pain due to endometriosis 6; the authors themselves describe the four studies evaluated there as of poor quality. Direct comparisons between micronised and ultramicronised PEA are still lacking. Two studies measured only endogenous PEA as a parameter, not the administered one 9; whether administration produces the same shifts has not yet been tested. For treatments longer than 60 days, the number of people studied is too small to rule out rare adverse effects 1.

4. What This Means in Everyday Life

Anyone reading the studies should distinguish three things: endogenous PEA, the administered food supplement and the formulation. “Nutraceutical” means PEA is taken supplementally like a food and is not tested like a classic medicinal product. Research is most robust for chronic pain; for areas such as metabolism, cognition or the immune system, individual studies exist but no comparably pooled evaluation. Also striking is how differently measurements are taken: sometimes pain scales, sometimes questionnaires on sleep and mood, sometimes blood values. These parameters are not the same as disease progression. The next thing to clarify is whether PEA also works without additives and whether the more finely ground formulations differ in direct comparisons.

All details with study numbers and sources: detailed page on palmitoylethanolamide (PEA). For children: palmitoylethanolamide (PEA) for children.